These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 11736864)

  • 1. An interaction between the cytochrome P450 probe substrates chlorzoxazone (CYP2E1) and midazolam (CYP3A).
    Palmer JL; Scott RJ; Gibson A; Dickins M; Pleasance S
    Br J Clin Pharmacol; 2001 Nov; 52(5):555-61. PubMed ID: 11736864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic assessment of a five-probe metabolic cocktail for CYPs 1A2, 3A4, 2C9, 2D6 and 2E1.
    Blakey GE; Lockton JA; Perrett J; Norwood P; Russell M; Aherne Z; Plume J
    Br J Clin Pharmacol; 2004 Feb; 57(2):162-9. PubMed ID: 14748815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of cytochrome P450 activity by a five-drug cocktail approach.
    Zhu B; Ou-Yang DS; Chen XP; Huang SL; Tan ZR; He N; Zhou HH
    Clin Pharmacol Ther; 2001 Nov; 70(5):455-61. PubMed ID: 11719732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isozyme-specific induction of low-dose aspirin on cytochrome P450 in healthy subjects.
    Chen XP; Tan ZR; Huang SL; Huang Z; Ou-Yang DS; Zhou HH
    Clin Pharmacol Ther; 2003 Mar; 73(3):264-71. PubMed ID: 12621391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail".
    Streetman DS; Bleakley JF; Kim JS; Nafziger AN; Leeder JS; Gaedigk A; Gotschall R; Kearns GL; Bertino JS
    Clin Pharmacol Ther; 2000 Oct; 68(4):375-83. PubMed ID: 11061577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of CYP2E1 and CYP3A enzymes in adults with moderate alcohol consumption: a comparison with nonalcoholics.
    Liangpunsakul S; Kolwankar D; Pinto A; Gorski JC; Hall SD; Chalasani N
    Hepatology; 2005 May; 41(5):1144-50. PubMed ID: 15841467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of chronic disulfiram administration on the activities of CYP1A2, CYP2C19, CYP2D6, CYP2E1, and N-acetyltransferase in healthy human subjects.
    Frye RF; Branch RA
    Br J Clin Pharmacol; 2002 Feb; 53(2):155-62. PubMed ID: 11851639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artemisinin antimalarials moderately affect cytochrome P450 enzyme activity in healthy subjects.
    Asimus S; Elsherbiny D; Hai TN; Jansson B; Huong NV; Petzold MG; Simonsson US; Ashton M
    Fundam Clin Pharmacol; 2007 Jun; 21(3):307-16. PubMed ID: 17521300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the five-drug "Pittsburgh cocktail" approach for assessment of selective regulation of drug-metabolizing enzymes.
    Frye RF; Matzke GR; Adedoyin A; Porter JA; Branch RA
    Clin Pharmacol Ther; 1997 Oct; 62(4):365-76. PubMed ID: 9357387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probe of CYP3A by a single-point blood measurement after oral administration of midazolam in healthy elderly volunteers.
    Krupka E; Venisse N; Lafay C; Gendre D; Diquet B; Bouquet S; Perault MC
    Eur J Clin Pharmacol; 2006 Aug; 62(8):653-9. PubMed ID: 16832678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver disease selectively modulates cytochrome P450--mediated metabolism.
    Frye RF; Zgheib NK; Matzke GR; Chaves-Gnecco D; Rabinovitz M; Shaikh OS; Branch RA
    Clin Pharmacol Ther; 2006 Sep; 80(3):235-45. PubMed ID: 16952490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis.
    Kharasch ED; Walker A; Hoffer C; Sheffels P
    Clin Pharmacol Ther; 2004 Nov; 76(5):452-66. PubMed ID: 15536460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic assessment of a five-probe cocktail for CYPs 1A2, 2C9, 2C19, 2D6 and 3A.
    Turpault S; Brian W; Van Horn R; Santoni A; Poitiers F; Donazzolo Y; Boulenc X
    Br J Clin Pharmacol; 2009 Dec; 68(6):928-35. PubMed ID: 20002088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lopinavir/ritonavir induces the hepatic activity of cytochrome P450 enzymes CYP2C9, CYP2C19, and CYP1A2 but inhibits the hepatic and intestinal activity of CYP3A as measured by a phenotyping drug cocktail in healthy volunteers.
    Yeh RF; Gaver VE; Patterson KB; Rezk NL; Baxter-Meheux F; Blake MJ; Eron JJ; Klein CE; Rublein JC; Kashuba AD
    J Acquir Immune Defic Syndr; 2006 May; 42(1):52-60. PubMed ID: 16639344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of incorporating flurbiprofen into the Pittsburgh cocktail.
    Zgheib NK; Frye RF; Tracy TS; Romkes M; Branch RA
    Clin Pharmacol Ther; 2006 Sep; 80(3):257-63. PubMed ID: 16952492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of a 'GW cocktail' of cytochrome P450 probe substrates and their metabolites in plasma and urine using automated solid phase extraction and fast gradient liquid chromatography tandem mass spectrometry.
    Scott RJ; Palmer J; Lewis IA; Pleasance S
    Rapid Commun Mass Spectrom; 1999; 13(23):2305-19. PubMed ID: 10567928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous phenotyping of CYP2E1 and CYP3A using oral chlorzoxazone and midazolam microdoses.
    Hohmann N; Blank A; Burhenne J; Suzuki Y; Mikus G; Haefeli WE
    Br J Clin Pharmacol; 2019 Oct; 85(10):2310-2320. PubMed ID: 31222796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450 2E1 and 3A activities do not differ between Mexicans and European Americans.
    Poland RA; Lin KM; Nuccio C; Wilkinson GR
    Clin Pharmacol Ther; 2002 Sep; 72(3):288-93. PubMed ID: 12235449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single plasma sampling to predict oral clearance of CYP3A probe midazolam.
    Zhu B; Ou-Yang DS; Cheng ZN; Huang SL; Zhou HH
    Acta Pharmacol Sin; 2001 Jul; 22(7):634-8. PubMed ID: 11749829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.
    Wang Z; Gorski JC; Hamman MA; Huang SM; Lesko LJ; Hall SD
    Clin Pharmacol Ther; 2001 Oct; 70(4):317-26. PubMed ID: 11673747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.